Neuropathologic, biochemical, and molecular characterization of the frontotemporal dementias

Journal of Neuropathology and Experimental Neurology

Volumn 64, Issue 5, 2005, Pages 420-428

  Mott, Ryan T ^a   Dickson, Dennis W ^b,c   Trojanowski, John Q ^d   Zhukareva, Vicki ^d   Lee, Virginia M ^d   Forman, Mark ^d   Van Deerlin, Vivianna ^d   Ervin, John F ^a   Wang, Deng Shun ^b   Schmechel, Donald E ^a   Hulette, Christine M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apolipoprotein E; Frontotemporal dementia; Frontotemporal lobar degeneration; Microtubule associated protein tau

Indexed keywords

APOLIPOPROTEIN E; TAU PROTEIN; UBIQUITIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BIOCHEMICAL COMPOSITION; CLINICAL FEATURE; CONSENSUS; CONTROLLED STUDY; CORTICOBASAL DEGENERATION; DISEASE CLASSIFICATION; FRONTOTEMPORAL DEMENTIA; GENE SEQUENCE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOTOR NEURON DISEASE; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PICK PRESENILE DEMENTIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; UBIQUITINATION; WESTERN BLOTTING;

EID: 20944438828     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/64.5.420     Document Type: Article

References (55)

1. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathologic diagnosis of frontotemporal dementia: Report of the work group on frontotemporal dementia and Pick's disease. Arch Neurol 2001;58:1803-9
2. Hodges JR. Frontotemporal dementia (Pick's disease): Clinical features and assessment. Neurology 2001;56:S6-10.
3. Kertesz A, Munoz DG. Frontotemporal dementia. Med Clin North Am 2002;86:501-18, vi
4. Pick A. Uber die Beziehungen der senilen Hirnatrophie zur Aphasie. Prager Med Wochenschr 1882;17:165-67
5. Pick A. Senile Hernatrophie als Grundlage von Herderscheinungen. Wien Klin Wochenschr 1901;14:403-4
6. Pick A. Zur Symptomatologie der linksseitigen Schlafenlappenatrophie. Monatschr Psychiatr Neurol 1904;16:378-88
7. Alzheimer A. Uber eigenartige Krankheitsfalle des spateren Alters. Z Gesamte Neurol Psychiatrie 1911;4:356-85
8. Altman A. Uber die umschriebene Gehirnatrophie des spateren Alters. Z Neurol Psychiatr 1923;83:610-43
9. Onari K, Spatz H. Anatomische Beitrage zur Lehre von der Pickschen Limschriebene-Grosshirnrinden-Atrophie ('Picksche Krankheit'). Z Gesamte Neurol Psychiatrie 1926;101:470-511
10. Constantinidis J, Richard J, Tissot R. Pick's disease. Histological and clinical correlations. Eur Neurol 1974;11:208-17
11. Hulette CM, Welsh-Bohmer KA, Crain B, Szymanski MH, Sinclaire NO, Roses AD. Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center experience. Arch Pathol Lab Med 1997;121:615-18
12. Liu WK, Le TV, Adamson J, et al. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. Ann Neurol 2001;50:494-502
13. Zhukareva V, Shah K, Uryu K, et al. Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer's disease, and Pick's disease: A comparative study. Am J Pathol 2002;161:1135-41
14. Zhukareva V, Sundarraj S, Mann D, et al. Selective reduction of soluble tau proteins in sporadic and familial frontotemporal dementias: An international follow-up study. Acta Neuropathol (Berl) 2003;105:469-76
15. Zhukareva V, Vogelsberg-Ragaglia V, Van Deerlin VM, et al. Loss of brain tau defines novel sporadic and familial tauopathies with frontotemporal dementia. Ann Neurol 2001;49:165-75
16. Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998;43:815-25
17. Crook R, Hardy J, Duff K. Single-day apolipoprotein E genotyping. J Neurosci Methods 1994;53:125-27
18. Barker WW, Luis CA, Kashuba A, et al. Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord 2002;16:203-12
19. Dickson DW, Bergeron C, Hauw JJ, Jellinger KA, Lantos PL, Mizusawa H, eds. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. Basel, Switzerland: ISN Neuropath Press, 2003
20. Buee L, Delacourte A. Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease. Brain Pathol 1999;9:681-93
21. Flament S, Delacourte A. Abnormal tau species are produced during Alzheimer's disease neurodegenerating process. FEBS Lett 1989;247:213-16
22. Flament S, Delacourte A, Verny M, Hauw JJ, Javoy-Agid F. Abnormal tau proteins in progressive supranuclear palsy. Similarities and differences with the neurofibrillary degeneration of the Alzheimer type. Acta Neuropathol (Berl) 1991;81:591-96
23. Delacourte A, Robitaille Y, Sergeant N, et al. Specific pathologic tau protein variants characterize Pick's disease. J Neuropathol Exp Neurol 1996;55:159-68
24. Forman MS, Zhukareva V, Bergeron C, et al. Signature tau neuropathology in gray and white matter of corticobasal degeneration. Am J Pathol 2002;160:2045-53
25. Arai T, Ikeda K, Akiyama H, et al. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol (Berl) 2001;101:167-73
26. Hutton M. Molecular genetics of chromosome 17 tauopathies. Ann NY Acad Sci 2000;920:63-73
27. Hutton M. Missense and splice site mutations in tau associated with FTDP-17: Multiple pathogenic mechanisms. Neurology 2001;56:S21-25
28. Ingram EM, Spillantini MG. Tau gene mutations: Dissecting the pathogenesis of FTDP-17. Trends Mol Med 2002;8:555-62
29. Lee VM, Goedert M, Trojanowski JQ. Neurodegenerative tauopathies. Annu Rev Neurosci 2001;24:1121-59
30. Tolnay M, Probst A. Frontotemporal lobar degeneration - tau as a pied piper? Neurogenetics 2002;4:63-75
31. Yoshiyama Y, Lee VM, Trojanowski JQ. Frontotemporal dementia and tauopathy. Curr Neurol Neurosci Rep 2001;1:413-21
32. Yamaoka LH, Welsh-Bohmer KA, Hulette CM, et al. Linkage of frontotemporal dementia to chromosome 17: Clinical and neuropathologic characterization of phenotype. Am J Hum Genet 1996;59:1306-12
33. D'Souza I, Schellenberg GD. tau exon 10 expression involves a bipartite intron 10 regulatory sequence and weak 5′ and 3′ splice sites. J Biol Chem 2002;277:26587-99
34. Goedert M, Spillantini MG, Crowther RA, et al. tau gene mutation in familial progressive subcortical gliosis. Nat Med 1999;5:454-57
35. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-5
36. Miyamoto K, Kowalska A, Hasegawa M, et al. Familial frontotemporal dementia and parkinsonism with a novel mutation at an intron 10+11-splice site in the tau gene. Ann Neurol 2001;50:117-20
37. Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci U S A 1998;95:7737-41
38. Stanford PM, Shepherd CE, Halliday GM, et al. Mutations in the tau gene that cause an increase in three repeat tau and frontotemporal dementia. Brain 2003;126:814-26
39. Yasuda M, Takamatsu J, D'Souza I, et al. A novel mutation at position +12 in the intron following exon 10 of the tau gene in familial frontotemporal dementia (FTD-Kumamoto). Ann Neurol 2000;47:422-29
40. Reed LA, Wszolek ZK, Hutton M. Phenotypic correlations in FTDP-17. Neurobiol Aging 2001;22:89-107
41. Reed LA, Grabowski TJ, Schmidt ML, et al. Autosomal dominant dementia with widespread neurofibrillary tangles. Ann Neurol 1997;42:564-72
42. Saito Y, Geyer A, Sasaki R, et al. Early-onset, rapidly progressive familial tauopathy with R406W mutation. Neurology 2002;58:811-13
43. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72
44. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-81
45. Fahre SF, Forsell C, Viitanen M, et al. Clinic-based cases with frontotemporal dementia show increased cerebrospinal fluid tau and high apolipoprotein E epsilon4 frequency, but no tau gene mutations. Exp Neurol 2001;168:413-18
46. Gustafson L, Abrahamson M, Grubb A, Nilsson K, Fex G. Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia. Dement Geriatr Cogn Disord 1997;8:240-43
47. Kalman J, Juhasz A, Majtenyi K, et al. Apolipoprotein E polymorphism in Pick's disease and in Huntington's disease. Neurobiol Aging 2000;21:555-58
48. Geschwind D, Karrim J, Nelson SF, Miller B. The apolipoprotein E epsilon4 allele is not a significant risk factor for frontotemporal dementia. Ann Neurol 1998;44:134-38
49. Hughes A, Mann D, Pickering-Brown S. tau haplotype frequency in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Exp Neurol 2003;181:12-16
50. Kowalska A, Asada T, Arima K, et al. Genetic analysis in patients with familial and sporadic frontotemporal dementia: Two tau mutations in only familial cases and no association with apolipoprotein epsilon4. Dement Geriatr Cogn Disord 2001;12:387-92
51. Minthon L, Hesse C, Sjogren M, Englund E, Gustafson L, Blennow K. The apolipoprotein E epsilon4 allele frequency is normal in frontotemporal dementia, but correlates with age at onset of disease. Neurosci Lett 1997;226:65-67
52. Pickering-Brown SM, Owen F, Isaacs A, et al. Apolipoprotein E epsilon4 allele has no effect on age at onset or duration of disease in cases of frontotemporal dementia with Pick- or microvacuolar-type histology. Exp Neurol 2000;163:452-56
53. Riemenschneider M, Diehl J, Muller U, Forstl H, Kurz A. Apolipoprotein E polymorphism in German patients with frontotemporal degeneration. J Neurol Neurosurg Psychiatry 2002;72:639-41
54. Verpillat P, Camuzat A, Hannequin D, et al. Apolipoprotein E gene in frontotemporal dementia: An association study and meta-analysis. Eur J Hum Genet 2002;10:399-405
55. Houlden H, Crook R, Backhovens H, et al. ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families. Am J Med Genet 1998;81:117-21